Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 20/20 | 1.00 |
| ▸ | ABL1 | P00519 | 3/20 | 0.77 |
| ▸ | EGFR | P00533 | 2/20 | 0.77 |
| ▸ | BCR | P11274 | 1/20 | 0.74 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.65 |
| ▸ | FYN | P06241 | 1/20 | 0.65 |
| ▸ | LYN | P07948 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4121727 | 1.00 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4134289 | 0.99 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4134294 | 0.99 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4116887 | 0.97 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4116894 | 0.97 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4123793 | 0.94 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4123796 | 0.94 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4127017 | 0.90 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4127022 | 0.90 | SRC (1.00) | SRCABL1EGFRBCRERBB2 | |
| SCHEMBL4123935 | 0.87 | SRC (0.98) | SRCABL1EGFRBCRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099356-A1 | PREPARATION OF 7-ALKENYL-3 QUINOLINECARBONITRILES VIA A PALLADIUM MEDIATED COUPLING REACTION | WYETH (US) | 2009-04-16 | — | — | US | claimed |
| US-20090099356-A1 | PREPARATION OF 7-ALKENYL-3 QUINOLINECARBONITRILES VIA A PALLADIUM MEDIATED COUPLING REACTION | WYETH (US) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099356-A1 | PREPARATION OF 7-ALKENYL-3 QUINOLINECARBONITRILES VIA A PALLADIUM MEDIATED COUPLING REACTION | PARK7, UQCRB, PRMT7 | SRC 3605/4885ABL1 64/4885EGFR 2351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.